Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine-Reference-Cited by-同舟云学术

Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine

Published:2012-05 Issue:22 Volume:30 Page:3266-3277
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Song Manki,Hong Huynh A.,Huang Jen-Min,Colenutt Claire,Khang Dinh Duy,Nguyen Thi Van Anh,Park Sung-Moo,Shim Byoung-Shik,Song Ho Hyun,Cheon In Su,Jang Ji Eun,Choi Jung-ah,Choi Young Ki,Stadler Konrad,Cutting Simon M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference56 articles.

1. Towards universal influenza vaccines?;Osterhaus;Philos Trans R Soc Lond B Biol Sci,2011

2. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile;WHO,2007

3. Development of vaccines against influenza H5;Stephenson;Lancet Infect Dis,2006

4. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines;Cox;Scand J Immunol,2004

5. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles;O‘Hagan;Mol Med Today,1997

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface Display of Duck Hepatitis A Virus Type 1 VP1 Protein on Bacillus subtilis Spores Elicits Specific Systemic and Mucosal Immune Responses on Mice;Probiotics and Antimicrobial Proteins;2024-07-13

2. Intranasal administration of DSM 32444 Bacillus subtilis spores: safety and tolerability;Journal of Medical Microbiology;2024-07-04

3. Mucosal Immunization with Spore-Based Vaccines against Mannheimia haemolytica Enhances Antigen-Specific Immunity;Vaccines;2024-04-01

4. Efficient symptomatic treatment and viral load reduction for children with influenza virus infection by nasal-spraying Bacillus spore probiotics;Scientific Reports;2023-09-08

5. An Attempt of a New Strategy in PRV Prevention: Co-Injection with Inactivated Enterococcus faecium and Inactivated Pseudorabies Virus Intravenously;Viruses;2023-08-17